Citadel Advisors’s InMed Pharmaceuticals INM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,833
| Closed | -$13.3K | – | 6358 |
|
|
2024
Q3 | $13.3K | Buy |
2,833
+2,228
| +368% | +$10.4K | ﹤0.01% | 5412 |
|
|
2024
Q2 | $3.21K | Sell |
605
-31
| -5% | -$165 | ﹤0.01% | 5626 |
|
|
2024
Q1 | $4.48K | Sell |
636
-1,064
| -63% | -$7.49K | ﹤0.01% | 5777 |
|
|
2023
Q4 | $14.1K | Buy |
+1,700
| New | +$14.1K | ﹤0.01% | 5461 |
|
|
2022
Q3 | – | Sell |
-26
| Closed | -$6K | – | 6277 |
|
|
2022
Q2 | $6K | Buy |
+26
| New | +$6K | ﹤0.01% | 5862 |
|
|
2022
Q1 | – | Sell |
-22
| Closed | -$14K | – | 6725 |
|
|
2021
Q4 | $14K | Sell |
22
-14
| -39% | -$8.91K | ﹤0.01% | 6341 |
|
|
2021
Q3 | $31K | Buy |
36
+5
| +16% | +$4.31K | ﹤0.01% | 6230 |
|
|
2021
Q2 | $49K | Sell |
31
-3
| -9% | -$4.74K | ﹤0.01% | 6207 |
|
|
2021
Q1 | $57K | Buy |
+34
| New | +$57K | ﹤0.01% | 6063 |
|